Back | Next |
home / stock / jagx / jagx message board
Subject | By | Source | When |
---|---|---|---|
My guess is $JAGX will dilute before any | mo 1 | investorshub | 06/12/2024 2:52:36 PM |
I also added the dip sitting at 1750. | scho1560 | investorshub | 06/12/2024 2:27:12 PM |
Because of the pending release, figuring with the | timberwolf7 | investorshub | 06/12/2024 2:17:11 PM |
as if on cue dropped 22 so far | scho1560 | investorshub | 06/12/2024 2:08:39 PM |
Good news from the aspect of the study | timberwolf7 | investorshub | 06/12/2024 2:04:24 PM |
Interesting we'll see how the market reacts now | scho1560 | investorshub | 06/12/2024 1:41:53 PM |
https://finance.yahoo.com/news/jaguar-health-report-pivotal-phase-123000319.html | ATM123 | investorshub | 06/12/2024 1:20:28 PM |
Well its possible he shorted at 30 cents | timberwolf7 | investorshub | 06/12/2024 12:40:00 PM |
can't lose shorting this? LOL.. | timberwolf7 | investorshub | 06/12/2024 12:37:26 PM |
I am going to mark this post LOL | ShadowDiviner72 | investorshub | 06/12/2024 11:07:53 AM |
I think that's just some static left over | Tom turtles | investorshub | 06/12/2024 4:30:10 AM |
Got a buy signal.. hmmm | timberwolf7 | investorshub | 06/11/2024 3:43:03 PM |
around 10000 shares changed hands in the first | timberwolf7 | investorshub | 06/11/2024 1:40:17 PM |
8K filing. More royalities (1,5million) converted into shares | ShadowDiviner72 | investorshub | 06/11/2024 8:24:07 AM |
$8s are soon.....probably before July!!! | Termite7 | investorshub | 06/11/2024 5:39:32 AM |
Lmao | Arcglass | investorshub | 06/10/2024 7:53:14 PM |
Yep, DIARREHA has that potential.. (smile) | timberwolf7 | investorshub | 06/10/2024 7:28:24 PM |
Potential to be explosive | oilin07 | investorshub | 06/10/2024 6:44:04 PM |
500%+ gains could be ahead | oilin07 | investorshub | 06/10/2024 4:40:21 PM |
Only a 1000 at the moment. Was | timberwolf7 | investorshub | 06/10/2024 4:39:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here ...
New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (...
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific ...